Latest

Fat

Home Fat

Fat

Salk Institute Research Reveals How Fat Driving Up Colorectal Cancer

February 25, 2019

Conatus Pharmaceuticals: third trial evaluating emricasan for NASH failed

March 23, 2019

Aerpio Therapeutics shares sink more than 70 percent following top-line results from TIME-2b trial...

March 23, 2019

Pfizer and Merck KgAa discontinue phase III trial; Use of Avelumab analyzed in untreated...

March 23, 2019

Biogen and Eisai’s Alzheimer’s drug aducanumab fails two phase III trials; $15 billion loss...

March 23, 2019

TrialSite News is the only digital media dedicated 100% to transparent and open coverage of clinical research trial sites around the globe. Based in the Silicon Slopes in downtown Salt Lake City, Utah, we are founded by a team of experts in the clinical trials industry and dedicated to transparency, quality and clinical trial innovation.

307 West 200 South #5002
Salt Lake City, UT 84101
Contact us: admin@trialsitenews.com

Privacy Policy

Contact

© TrialSite News, Inc. All Rights Reserved

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok

Edit with Live CSS

Save
Write CSS OR LESS and hit save. CTRL + SPACE for auto-complete.

Salk Institute Research Reveals How Fat Driving Up Colorectal Cancer

EDITOR PICKS

Conatus Pharmaceuticals: third trial evaluating emricasan for NASH failed

Aerpio Therapeutics shares sink more than 70 percent following top-line results from TIME-2b trial...

Pfizer and Merck KgAa discontinue phase III trial; Use of Avelumab analyzed in untreated...

Biogen and Eisai’s Alzheimer’s drug aducanumab fails two phase III trials; $15 billion loss...